cerrar
Tagged with Access

Mylan’s Arun Narayan Emphasizes Benefits of Value Added…
Arun Narayan of Medicines for Europe’s Value Added Medicines Group has been working to promote the benefits of value added medicines and how…

Emelie Antoni – Country President, AstraZeneca Czech…
Emelie Antoni joined AstraZeneca in Sweden 20 years ago, evolving in global, regional and local roles. Last year, she became country manager for Czech…

Arun Narayan – Chairman, Value Added Medicines Group,…
Arun Narayan is the Chairman of the Value Added Medicines Sector Group at Medicines for Europe, in addition to serving as Head of Global Portfolio…

European Cancer Forum 2020: Belgian MoH Maggie De Block Delivers…
The second edition of the European Cancer Forum was held in Brussels, Belgium on Tuesday, 29 January 2020. Hosted by MSD in collaboration with the…

Krisztina Kárpát – Managing Director & CFO, Bayer…
Krisztina Kárpát, MD of Bayer Hungary, elaborates on the successful development of the affiliate in recent years, making progress in all three…

Hungary: Entering a New Age of Patient Access?
In 2016, Hungary transitioned from a second-tier member to a full member of the EU. As Judit Bidló, deputy director general of pricing and…

Katinka Zinnemers – Managing Director, Abacus Medicine,…
Katinka Zinnemers, managing director of Abacus Medicine, highlights the company's mission to increase access to medicines for all patients and its…

Miha Kline – Country Manager, Eli Lilly Czech Republic…
Miha Kline has been with Eli Lilly for the past 15 years, becoming Country Manager Czech Republic and Slovakia four years ago. Kline shares his…

Francesco Banchi – General Manager, Boehringer Ingelheim…
Francesco Banchi, general manager of Boehringer Ingelheim Hungary, elaborates on the successful development of the affiliate in recent years, making…

Mexico: Despite Hurdles, Pharma Market Remains Attractive
The United States Trade Representative Office has been engaging with a number of countries, including Mexico, to address concerns related to IP…

Biocon’s New Facility & Expansion in APAC
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with a new manufacturing facility and an…

FDA Drugs Approved in 2019
In 2019, the US FDA's Center for Drug Evaluation and Research approved 42 novel drugs, down from 59 drugs approved in 2018. Novartis had four drugs…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here